Overview
| Name | BindCraft · aliases: BindCraft |
|---|---|
| Full name | Sources use BindCraft only; no expanded name |
| Ambiguous names (not auto-linked) | None |
| Family | Not a family entry. A single pipeline with version iterations; no family members |
| Organization | EPFL Laboratory of Protein Design and Immunoengineering, MIT |
| Organization type | Academic lab |
| Country | Switzerland |
| Model class | Design (hallucination via backpropagation) |
| Domain | Proteins (also: Molecule generation) |
| First release | · preprint Basis: bioRxiv v1 (later v2 2024-12-07, v3 2025-04-25) source |
| Other milestones |
|
| Latest update | · patch Basis: Tag v1.5.3 (small fixes) v1.5.3 small fixes; the journal version online 2025-08-27 is a separate milestone; commits to 2026-09-21 are install and notebook maintenance. Note: The earlier record treated this date as the journal publication; corrected to a patch source The most recent sourced event, not a claim that nothing changed since. |
| Status | Active · Tagged release and ongoing commits within 12 months |
| Openness | Code: Open Weights: Unclear Code is open; it has no weights of its own and depends on a third-party co-folding model's weights and licence |
| Benchmarks reported | 1 counted (board 1) |
| Wet-lab validation | 1 recorded campaign |
| Unverified fields | † release_milestones.code_release, benchmarks_reported[0], open_status.weights |
| As of | 2026-11-16 |
What it does
It folds target and binder together in a co-folding network and iteratively edits the binder sequence to maximise predicted confidence, allowing some induced fit; there is no generative model and no training. Compared with RFdiffusion2/3, BoltzGen and Germinal it is the lightest and easiest to reproduce.
Benchmarks reported
Every row is one pairing from the survey's relation file; a score belongs to the benchmark page's ranking, where it is shown with metric, eval set, source type and date. 1 of 1 pairings are counted.
| Benchmark | Relation | Eval set / protocol | Source type | Note and evidence |
|---|---|---|---|---|
| 28 Adaptyv competitions / BenchBB | Official leaderboard or results | Nipah and EGFR rounds | Board | The developers took part; an early-round top-10 placement comes from an organiser post (second-hand) †partly verified · evidence |
Other evaluations (outside the 44)
- Own 12-target wet-lab set (Wet-lab validation) Self-reported: Self-chosen targets with the share of tested designs that bound; per-target denominators are very small (self-reported)
- Application demonstrations (Case study) Self-reported: Binders blocking a pollen allergen and peptides improving a gene-therapy vector; the authors say they are extending to peptides
Developers report: Developers report that with no extra training most targets yield binders in one design round, with about 46.3% of tested designs binding (journal body text, self-reported).
Independent evidence: No independent evidence found. The competition publishes no per-tool hit rates, so performance there rests on entrants' own accounts (second-hand)
Training data
Group in Figure 7: Public data + wet lab for validation only.
| Class | Value | Detail |
|---|---|---|
| a. Public databases | Yes | No training of its own; it uses a third-party co-folding model's off-the-shelf weights, trained on PDB and other public data source |
| b. Private or licensed data | No | No private or licensed data source |
| c. Own wet-lab data used for training | No | No own training data source |
| d. Wet lab used only for validation | Yes | Yes: the authors ran the wet-lab validation themselves source |
Wet-lab validation
Every rate carries its numerator and denominator. Claims that could not be verified are shown as unverified, without numbers; different paper versions are separate entries.
Denominator basis: Twelve targets; the rate is the share of tested designs that bound, and per-target denominators are very small
The 46.3% figure is stated directly in the journal body text, so the earlier 'second-hand summary' label is dropped; the authors ran the experiments themselves, so this is not independent replication
Background
- Organization: An academic project of a protein design and immunoengineering laboratory in the engineering school of a Swiss institute of technology, with no company entity; the university's news release describes collaboration with a US university and researchers from Switzerland, the US and the Netherlands.
- Funding: Grants are listed only in the journal acknowledgements, not in the news release
- Products and partnerships: Academic project; no product and no pharma partnership
- Related models: RFdiffusion2 / RFdiffusion3, BoltzGen, Germinal, Mosaic
Reading notes
- The 10-100% span is wide and its average depends on target choice, so it is not an expected rate for an arbitrary target.
- Optimising a co-folding confidence score as the design objective disqualifies that score as an independent filter, a known issue for this family.
- The Adaptyv competition does not report per tool, so performance there rests on entrants' own accounts.
- Being open and training-free is why it is so widely used as a baseline.
Caveats
- The success rate is the share of tested designs that bound, with very small per-target denominators.
- It reports no site benchmark score; its only pairing is a competition entry record (second-hand).
- It has no weights of its own, so design quality inherits the biases of the co-folding model it depends on.
- The repository's first release date is unverified.
Sources
- Journal paper DOI (journal) ·
- Journal article page (journal)
- Official repository releases (repository)
- University news release (press)
- Competition results blog (second-hand) (second-hand) second-hand
Corrections
2 corrections
| Field | Was | Now | Basis | Found |
|---|---|---|---|---|
| latest_update.event_kind | 2026-04-17 was recorded as the journal publication | That date is the v1.5.3 small fix, so the kind becomes patch; the journal version online 2025-08-27 is listed separately | source | 2026-11-16 |
| wetlab_validation | The 46.3% average was labelled a second-hand summary | The figure is stated directly in the journal body text, so the second-hand label is dropped; the rate is the share of tested designs that bound | source | 2026-11-16 |
Part of the AI for Bio benchmarks survey · all 112 models · open in the explorer. Record as of 2026-11-16.